Translocation t(9;22) (p23;q11) in atypical chronic myeloid leukemia (aCML) presenting osteolytic lesions

International Journal of Hematology

Volumn 76, Issue 4, 2002, Pages 344-348

  Muta, Tsuyoshi ^a   Osaki, Koichi ^a   Yamano, Yujirou ^a  

^a KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Atypical chronic myeloid leukemia; Osteolytic lesions; t(9; 22)(p23; q11)

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; PARATHYROID HORMONE;

ADULT; ANAMNESIS; ARTICLE; ATYPICAL CHRONIC MYELOID LEUKEMIA; BONE ATROPHY; BONE PAIN; BONE RADIOGRAPHY; CANCER GROWTH; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE IDENTIFICATION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; MALE; BRAIN HEMORRHAGE; CANCER INVASION; CHROMOSOME 22; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; FATALITY; FEMUR; GENETICS; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY;

CEREBRAL HEMORRHAGE; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DISEASE PROGRESSION; FATAL OUTCOME; FEMUR; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIC INFILTRATION; MALE; MIDDLE AGED; OSTEOLYSIS; TRANSLOCATION, GENETIC;

EID: 1842852794     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982694     Document Type: Article

References (14)

1. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Br J Haematol. 1994;87:746-754.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: World Health Organization Classification of Tumours. Lyon: IARC Press; 2001.
3. Chabner BA, Haskell CM, Canellos GP. Destructive bone lesions in chronic granulocytic leukemia. Medicine. 1969;48:401-410.
4. Kumar L, Majhi U, Shanta V. Destructive bone lesions in chronic granulocytic leukemia. Indian J Cancer. 1990;27:208-210.
5. Ohri SK, Sharp DJ, Coutts GB. Osteolytic lesions in chronic myelomonocytic leukaemia. Br J Clin Pract. 1990;44(12):672-673.
6. Mehta AB, Castro JT, San Miguel JF, et al. Osteolytic lesion as the presenting feature of chronic granulocytic leukaemia. Clin Lab Haematol. 1985;7(2):105-112.
7. Murata T, Motomura S, Harano H, et al. Hypercalcemia associated with blast crisis of chronic myeloid leukemia. Rinsho Ketsueki. 1990;31(2):177-182.
8. Tricot G, Boogaerts MA, Orshoven AB, et al. Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. Cancer. 1983;52(5):841-845.
9. Kubota K, Yanagisawa T, Kurabayashi H, et al. Hypercalcemia associated with osteolytic lesions in the extramedullary blastic crisis of chronic myelogenous leukemia: report of a case. Blut. 1989;59(5):458-459.
10. Taillan B, Ferrari E, Garnier G, et al. Hypercalcemia and diffuse osteolytic lesions in the acute phase of myeloid splenomegaly. Clin Rheumatol. 1992;11(4):580.
11. Fuzesi L, Gunawan B, Braun S, Boeckmann W. Renal oncocytoma with a translocation t(9;11)(p23;q13). Pt 1. J Urol. 1994;152(2):471-472.
12. Joos S, Kupper M, Ohl S, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res. 2000;60(3):549-552.
13. Weber T, Weber RG, Kaulich K, et al. Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type. Brain Pathol. 2000;10(1):73-84.
14. Savelyeva L, Claas A, Matzner I, et al. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res. 2001;61(13):5179-5185.